Study: New gene editing strategy effectively targets cancer-causing ‘fusion genes’ in mouse models

Short resume:

gene
90%
cells
80%
editing
80%
genes
70%

A novel gene therapy using CRISPR genome editing technology effectively targets cancer-causing fusion genes and improves survival in mouse models of aggressive liver and prostate cancers, University of Pittsburgh School of Medicine researchers report …
Source News-Medical.net
Read More…

Other News

Be the first to comment

Leave a Reply

Your email address will not be published.


*